Karthik Subramanian

4PUBLICATIONS
10CO-AUTHORS
Medical infection agents (incl. prions)Toxicology (incl. clinical toxicology)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 16, 2026
Sorafenib, a clinical kinase inhibitor, attenuates Streptococcus pneumoniae pathogenesis and reduces disease progression in vivo.

|Sep 28, 2020
Mannose receptor-derived peptides neutralize pore-forming toxins and reduce inflammation and development of pneumococcal disease.

Karthik Subramanian, Federico Iovino, Vasiliki Tsikourkitoudi

|Jun 29, 2019
Emerging concepts in the pathogenesis of the Streptococcus pneumoniae: From nasopharyngeal colonizer to intracellular pathogen.

Karthik Subramanian, Birgitta Henriques-Normark, Staffan Normark

|Nov 14, 2018
Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival.

Karthik Subramanian, Daniel R Neill, Hesham A Malak

Pageof 1

Frequent Collaborators

3 joint publications

Birgitta Henriques-Normark

1 joint publications

Daniel R Neill

1 joint publications

Alun Kirby

1 joint publications

Johan Nilvebrant